Advertisement

AVGR

Avinger, Inc.

Healthcare

Set alert

Price alert · AVGR

All alert types
0.47 0.00 0.00%
As of Feb 14, 2025
0.4633 Day range 0.6058

52-week range unavailable

YTD
-42.05%
1 year
-83.66%
Open
0.5561
Prev close
0.474
Mkt cap
4.64M
Vol
2.59M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.4633
High
0.6058
Forward P/E
-1.23
Beta
1.16
Short ratio
0.22
Inst. own
2.84%
Dividend
0.00
Ex-div date
50-d avg
0.79086
200-d avg
1.82
1y target
5.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for AVGR has not been loaded yet. Try again in a moment.

Key statistics

Market cap
4.64M
Enterprise value
-1.19M
Trailing P/E
0.00
Forward P/E
-1.23
PEG ratio
0.00
Price / sales
0.62
Price / book
0.00
EPS (TTM)
-8.76
Beta
1.16
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-260.86%
Revenue (TTM)
7.43M
Revenue growth
-9.50%
Free cash flow
-9.95M
Total cash
8.81M
Total debt
5.75M
Return on equity
-3332.59%
Shares outstanding
3.20M
Short % of float
6.10%
50-day average
0.79086
200-day average
1.82

Analyst view

Consensus: none

Price target (mean) 5.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
AVGR Revenue — quarterly 1.65M
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 2024
AVGR Net income — quarterly -3.71M
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 2024
AVGR EPS — quarterly -1.82
2020-Q4 20202021-Q1 20212021-Q2 20212021-Q3 20212021-Q4 20212022-Q1 20222022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 2024

Earnings

AVGR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 7, 2024Sep 1, 2024-2.03-1.82+0.21+10.34%
Aug 8, 2024Jun 1, 2024-0.43-2.82-2.39-555.81%
May 15, 2024Mar 1, 2024-1.35-2.49-1.14-84.44%
Mar 20, 2024Dec 1, 20230.64-3.93-4.57-714.06%
Oct 26, 2023Sep 1, 2023-2.85-2.92-0.07-2.46%
Jul 27, 2023Jun 1, 2023-7.35-8.85-1.50-20.41%

Upgrades / downgrades

AVGR analyst upgrades and downgrades
DateFirmActionFromTo
Mar 21, 2024HC Wainwright & Co.reitBuyBuy
Mar 8, 2024HC Wainwright & Co.mainBuyBuy
Nov 13, 2023HC Wainwright & Co.mainBuyBuy

About Avinger, Inc.

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Website
avinger.com

News

Your note

Sign in to keep a note on AVGR — it syncs with the Stock Master app.

Insider holders

AVGR insider holders
InsiderRelationLatest transactionDateShares held
CULLEN JAMES GDirectorStock Award(Grant)Jan 10, 202429,895
ELIAS TAMARA N. M.D.DirectorStock Award(Grant)Jan 10, 202429,962
MCELWEE JAMES BDirectorStock Award(Grant)Jan 10, 202429,895
PATEL HIMANSHU TChief Technology OfficerStock Award(Grant)Jan 17, 202441,277
SOINSKI JEFFREY MARTINChief Executive OfficerStock Award(Grant)Jan 17, 202458,955
SUBAINATI NABEEL PAULOfficerSaleMar 22, 202385,672

Institution ownership

AVGR institution ownership
Holder% heldSharesValueReported
Armistice Capital, LLC2.45%81,000117.45KSep 29, 2024
UBS Group AG0.79%26,17437.95KSep 29, 2024
Vanguard Group Inc0.72%23,80234.51KSep 29, 2024
Blackrock Inc.0.15%4,8977.10KSep 29, 2024
Tower Research Capital LLC (TRC)0.12%4,1255.98KSep 29, 2024
City State Bank0.01%225326Sep 29, 2024

Fund ownership

AVGR fund ownership
Holder% heldSharesValueReported
Vanguard Extended Market Index Fund0.72%23,80234.51KSep 29, 2024
Fidelity Extended Market Index Fund0.21%6,93910.06KOct 30, 2024
Fidelity Series Total Market Index Fund0.09%2,8594.14KOct 30, 2024
Fidelity Total Market Index Fund0.02%513743Oct 30, 2024
Blackstone Alternative Multi-Strategy Fund0.00%3449Sep 29, 2024
Advertisement